Roche has launched a large-scale AI computing infrastructure powered by more than 3,500 NVIDIA Blackwell GPUs, deployed across hybrid-cloud and on-premises environments in the United States and Europe, the company announced on March 16, 2026, at NVIDIA’s GTC conference. AI
“It costs about $2.5 billion to bring a drug to the market, and only about 30% of those actually succeed or meet their commercial goals when they get to the market.” Manufacturing leaders typically focus on the technical challenges directly
At Nordic Life Science Days (NLSDays), Microsoft and Cegeka explored how pharmaceutical companies can adopt AI-powered automation while maintaining regulatory compliance. The workshop covered practical applications of AI agents already in production, compliance-ready ERP implementation strategies, and the business case
Artificial intelligence (AI) agents could dramatically accelerate clinical drug development, delivering 35 to 45 percent productivity gains across all clinical functions while cutting trial design timelines in half, according to a comprehensive analysis from McKinsey & Company. The consulting firm’s
New research from PharmaSource and MasterControl reveals the reality behind AI manufacturing
Online Webinar / 4th December 2025
